{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Ind-Swift Laboratories Ltd
Ind-Swift Laboratories Ltd Hits All-Time High of Rs 418.1 as Momentum Builds Across Timeframes
Ind-Swift Laboratories Ltd, a key player in the Pharmaceuticals & Biotechnology sector, achieved a significant milestone on 24 September 2026 by reaching an all-time high stock price of Rs.418.1. This marks a remarkable ascent for the micro-cap company, reflecting strong market performance and sustained investor confidence over recent months.
Broad-Based Technical Strength Lifts Ind-Swift Laboratories Ltd to 52-Week High of Rs 408
Surging to an all-time high of Rs 408 on 22 Sep 2026, Ind-Swift Laboratories Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market with a 286.83% gain over the past year. This milestone reflects a confluence of strong technical signals that have propelled the stock well above its 52-week low of Rs 87.
Ind-Swift Laboratories Ltd Hits All-Time High of Rs 404.35 as Momentum Builds Across Timeframes
Ind-Swift Laboratories Ltd has reached a new all-time high on 22 September 2026, reflecting a remarkable performance trajectory in the Pharmaceuticals & Biotechnology sector. The stock’s surge underscores the company’s sustained growth and resilience amid a competitive market landscape.
Ind-Swift Laboratories Ltd is Rated Hold
Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 September 2026, providing investors with the latest insights into its performance and outlook.
Ind-Swift Laboratories Gains 8.79%: 4 Key Factors Driving the Move
Ind-Swift Laboratories Ltd delivered a strong weekly performance, rising 8.79% from Rs.354.90 to Rs.386.10 between 7 and 11 September 2026, significantly outperforming the Sensex which declined 1.68% over the same period. The stock hit multiple new 52-week and all-time highs amid sustained buying momentum and positive technical signals, despite a broadly weak market backdrop.
Broad-Based Technical Strength Lifts Ind-Swift Laboratories Ltd to 52-Week High of Rs 402
Delivering a remarkable 268.36% return over the past year, Ind-Swift Laboratories Ltd surged to a fresh 52-week high of Rs 402 on 09 Sep 2026, defying the broader market's subdued tone. This milestone caps a three-day winning streak that has propelled the stock 11.58% higher, underscoring the powerful momentum behind this rally.
Ind-Swift Laboratories Ltd Hits All-Time High of Rs 398.10 as Momentum Builds Across Timeframes
Ind-Swift Laboratories Ltd has reached a new all-time high on 09 Sep 2026, reflecting a remarkable performance trajectory in the Pharmaceuticals & Biotechnology sector. The stock’s surge underscores the company’s sustained momentum and robust market presence, culminating in a milestone that highlights its growth over recent years.
Ind-Swift Laboratories Ltd is Rated Hold
Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 09 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Broad-Based Technical Strength Lifts Ind-Swift Laboratories Ltd to 52-Week High of Rs 402
Surging past its previous peaks, Ind-Swift Laboratories Ltd touched a fresh 52-week high of Rs 402 on 08 Sep 2026, marking a remarkable rally from its 52-week low of Rs 87. This milestone reflects a sustained momentum driven by a confluence of bullish technical indicators despite a broadly weakening market backdrop.
Ind-Swift Laboratories Ltd Hits All-Time High of Rs 390 as Momentum Builds Across Timeframes
Ind-Swift Laboratories Ltd has reached a significant milestone by touching an all-time high price of Rs. 390 on 08 Sep 2026, marking a remarkable phase in the company’s market performance within the Pharmaceuticals & Biotechnology sector.
Ind-Swift Laboratories Ltd Falls 2.23%: 5 Key Factors Driving the Weekly Move
Ind-Swift Laboratories Ltd experienced a volatile week ending 04 September 2026, closing at Rs.354.90, down 2.23% from the previous Friday’s close of Rs.363.00. Despite this decline, the stock outperformed the Sensex, which fell 1.11% over the same period. The week was marked by a new 52-week high and an all-time peak on 01 September, followed by a sharp correction on the final trading day, reflecting mixed investor sentiment amid broader market weakness.
Broad-Based Technical Strength Lifts Ind-Swift Laboratories Ltd to 52-Week High of Rs 373.9
With a remarkable ascent from Rs 87 to nearly Rs 374 in the past year, Ind-Swift Laboratories Ltd has surged over 287%, outpacing the Sensex's decline of 4%. This rally culminated in the stock touching its 52-week high on 1 Sep 2026, fuelled predominantly by a confluence of strong technical indicators and sustained price momentum.
Ind-Swift Laboratories Ltd Hits All-Time High of Rs 378.75 as Momentum Builds Across Timeframes
Ind-Swift Laboratories Ltd has reached an all-time high price of Rs. 378.75 on 01 Sep 2026, underscoring a remarkable period of growth and resilience in the Pharmaceuticals & Biotechnology sector. This milestone reflects the company’s sustained upward momentum and strong market performance over recent months and years.
Ind-Swift Laboratories Gains 10.22%: 2 Key Milestones Drive the Surge
Ind-Swift Laboratories Ltd delivered a strong weekly performance, rising 10.22% from Rs.329.35 to Rs.363.00 between 24 and 28 August 2026, significantly outperforming the Sensex which declined marginally by 0.05% over the same period. The stock’s rally was propelled by the achievement of a new 52-week high and an all-time high on 26 August, supported by robust volume and positive technical indicators.
Ind-Swift Laboratories Ltd is Rated Hold
Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 29 August 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Broad-Based Technical Strength Lifts Ind-Swift Laboratories Ltd to 52-Week High of Rs 356.15
From a 52-week low of Rs 87 to a fresh peak of Rs 356.15, Ind-Swift Laboratories Ltd has surged an impressive 280.75% over the past year, significantly outperforming the Sensex which declined by 3.73% during the same period. This remarkable rally culminated in the stock hitting a new all-time high on 26 Aug 2026, fuelled by a confluence of strong technical signals and sustained price momentum.
Ind-Swift Laboratories Ltd Hits All-Time High of Rs 355.75 as Momentum Builds Across Timeframes
Ind-Swift Laboratories Ltd has reached a new all-time high on 26 August 2026, reflecting a remarkable performance trajectory in the Pharmaceuticals & Biotechnology sector. The stock’s surge to Rs 355.75 marks a pivotal moment for the micro-cap company, underscoring its sustained upward momentum and robust market presence.
Ind-Swift Laboratories Gains 8.27%: Key Milestones and Market Dynamics This Week
Ind-Swift Laboratories Ltd delivered a robust weekly performance, gaining 8.27% from Rs.304.20 to Rs.329.35 between 17 and 21 August 2026, significantly outperforming the Sensex which declined by 0.40% over the same period. The stock’s rally was marked by a new 52-week high and an all-time peak on 18 August, reflecting strong momentum amid a mixed market backdrop.
Ind-Swift Laboratories Ltd is Rated Hold
Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 18 August 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
